Richard L. Wynn, PhD, is professor emeritus of pharmacology in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry.

He is a nationally recognized speaker, author, columnist, and consultant on dental drug therapeutics and drug information for the dental professional. He is the lead author of the most recognized chairside dental drug reference book, Drug Information Handbook for Dentistry, now in its 29th edition.

Dr. Wynn keeps the dental profession informed about current issues relative to drugs in dentistry, including new therapeutic agents, new drug interactions, and newly reported adverse reactions in dental patients. He researches the literature daily for new reports of interest to the profession.  

This course, provides an in-depth exploration of the oral administration of sedative drugs, with a focus on benzodiazepines. The course covers pharmacokinetics, drug metabolism, and the specific properties and uses of various benzodiazepines in dental practice. Participants will gain a thorough understanding of the advantages and disadvantages of oral sedation, as well as the pharmacological actions of key benzodiazepines.

• Program Four: Oral Administration and Benzodiazepines
  • Part 1: Oral Administration of Drugs, Kinetics and Metabolism
  • Part 2: Benzodiazepine Clinical Applications

Upon completion of Program Four, participants will be able to:

• Identify a primary goal of oral sedation.
• Define first-pass metabolism and its implications.
• Define drug half-life and its clinical significance.
• Describe the molecular mechanism of benzodiazepines.

Upon completion of the online course, participants are required to pass an online post-course assessment with a minimum grade of 75%.

Once the online course has been accessed, no refunds will be provided.

Cancellation and Refund Policies